Unveiling the antiophidian potential of epicatechin and isoquercetin from Tapinanthus globiferus growing on Acacia nilotica: An in silico and in vitro studies
Amina Jega Yusuf , Musa Sadiq , Aisha Iliyasu Bugaje , Mustapha Salihu , Abimbola M. Oluwajembola , Olayinka S. Okoh
{"title":"Unveiling the antiophidian potential of epicatechin and isoquercetin from Tapinanthus globiferus growing on Acacia nilotica: An in silico and in vitro studies","authors":"Amina Jega Yusuf , Musa Sadiq , Aisha Iliyasu Bugaje , Mustapha Salihu , Abimbola M. Oluwajembola , Olayinka S. Okoh","doi":"10.1016/j.prenap.2025.100197","DOIUrl":null,"url":null,"abstract":"<div><div>Traditional medicine offers potential therapeutic options to myriad form of diseases that appear incurable. This study investigated the inhibitory potential of Epicatechin and Isoquercetin isolated from <em>Tapinanthus globiferus</em> growing on <em>Acacia nilotica</em> against <em>Naja nigricollis</em> phospholipase A<sub>2</sub> (PLA<sub>2</sub>) enzyme. <em>In vitro</em> PLA<sub>2</sub> activity was assayed using an acidimetric method. <em>In silico</em> analysis of docking scores and pharmacokinetic properties were performed using established softwares (Autodock Vina, SwissADME, ProTox-II). Both Epicatechin and Isoquercetin exhibited concentration-dependent inhibition of PLA<sub>2</sub> enzyme activity, with Epicatechin demonstrating a more potent effect (inhibition range: 34.40 – 63.70 %) compared to Isoquercetin (25.42 – 57.18 %) at tested concentrations. <em>In silico</em> docking scores indicated favorable binding affinities for both compounds (-8.0 and −8.1 kcal/mol for Epicatechin and Isoquercetin, respectively). Toxicity studies predicted a relatively low hazard profile for both compounds (LD<sub>50</sub> > 5000 mg/kg). ADME/Tox analysis suggested better lead-like properties for Epicatechin. In conclusion, Epicatechin and Isoquercetin isolated from <em>T. globiferus</em> exhibited promising anti-snake venom activity against <em>N. nigricollis</em> PLA<sub>2</sub> enzyme in both <em>in vitro</em> and <em>in silico</em> analyses. Epicatechin demonstrated superior enzyme inhibitory activity and favorable pharmacokinetic properties, warranting further investigation for potential development as a snakebite therapeutic.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"6 ","pages":"Article 100197"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950199725000576","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Traditional medicine offers potential therapeutic options to myriad form of diseases that appear incurable. This study investigated the inhibitory potential of Epicatechin and Isoquercetin isolated from Tapinanthus globiferus growing on Acacia nilotica against Naja nigricollis phospholipase A2 (PLA2) enzyme. In vitro PLA2 activity was assayed using an acidimetric method. In silico analysis of docking scores and pharmacokinetic properties were performed using established softwares (Autodock Vina, SwissADME, ProTox-II). Both Epicatechin and Isoquercetin exhibited concentration-dependent inhibition of PLA2 enzyme activity, with Epicatechin demonstrating a more potent effect (inhibition range: 34.40 – 63.70 %) compared to Isoquercetin (25.42 – 57.18 %) at tested concentrations. In silico docking scores indicated favorable binding affinities for both compounds (-8.0 and −8.1 kcal/mol for Epicatechin and Isoquercetin, respectively). Toxicity studies predicted a relatively low hazard profile for both compounds (LD50 > 5000 mg/kg). ADME/Tox analysis suggested better lead-like properties for Epicatechin. In conclusion, Epicatechin and Isoquercetin isolated from T. globiferus exhibited promising anti-snake venom activity against N. nigricollis PLA2 enzyme in both in vitro and in silico analyses. Epicatechin demonstrated superior enzyme inhibitory activity and favorable pharmacokinetic properties, warranting further investigation for potential development as a snakebite therapeutic.